Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
8 pending office actions • 3 art units • 3 examiners • 0 of 8 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Ketoneaid Inc. currently has 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 6 actions are being handled by 3 distinct examiners, which indicates a concentration of matters among a small group of personnel. The portfolio is also distributed across 3 distinct art units, suggesting that the company's Biotechnology & Pharmaceuticals applications are evaluated by several specialized technical groups within the patent office.
The busiest examiner for the portfolio is Stulii, Vera, who is responsible for 3 of the pending office actions. Since Stulii, Vera manages 3 out of the 6 total actions, this examiner's specific feedback and requirements will be a dominant factor in the company's current prosecution efforts. The 3 distinct art units involved mean that the 6 pending office actions are subject to the specific guidelines of three different examination groups, requiring a tailored approach for each case.
Practitioners managing these 6 pending office actions must prioritize the relationship with Stulii, Vera, given their oversight of 3 cases. The presence of 3 distinct examiners and 3 distinct art units for 6 actions shows that the portfolio is distributed across multiple procedural silos. This distribution requires a strategy that addresses the specific technical nuances of each Biotechnology & Pharmaceuticals art unit while managing the significant influence of the busiest examiner on the overall portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (25%) |
| Double-patenting only | 2 (25%) |
| Double-patenting + other | 2 (25%) |
| Multi-statute (no §101) | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRONDA, CHRISTIAN L | 4 | 82.4% | +14.2% |
| STULII, VERA | 3 | 32.8% | +24.8% |
| ZILBERING, ASSAF | 1 | 35.2% | +27.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18678629 | EXOGENOUS KETONE BLEND COMPOSITIONS FOR DELIVERY OF KETONE BODIES | FRONDA, CHRISTIAN L | 4d overdue |
| 19676472 | FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY | FRONDA, CHRISTIAN L | — |
| 19578476 | R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT | FRONDA, CHRISTIAN L | — |
| 19544207 | COMPOSITION OF D B-HYDROXYBUTYRATE SALTS | FRONDA, CHRISTIAN L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19534368 | BEVERAGE CONTAINING R 1,3 BUTANEDIOL | STULII, VERA | — |
| 19174611 | KETONE BEVERAGE CONTAINING CAFFEINE AND (R)-1,3-BUTANEDIOL AND/OR (R)-BETA-HYDROXYBUTYRIC ACID AND SALTS | ZILBERING, ASSAF | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18678629 | EXOGENOUS KETONE BLEND COMPOSITIONS FOR DELIVERY OF KETONE BODIES | FRONDA, CHRISTIAN L | 4d overdue |
| 19676472 | FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY | FRONDA, CHRISTIAN L | — |
| 19578476 | R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT | FRONDA, CHRISTIAN L | — |
| 19544207 | COMPOSITION OF D B-HYDROXYBUTYRATE SALTS | FRONDA, CHRISTIAN L | — |
| 19534368 | BEVERAGE CONTAINING R 1,3 BUTANEDIOL | STULII, VERA | — |
| 19174611 | KETONE BEVERAGE CONTAINING CAFFEINE AND (R)-1,3-BUTANEDIOL AND/OR (R)-BETA-HYDROXYBUTYRIC ACID AND SALTS | ZILBERING, ASSAF | — |
| 18894874 | BEVERAGE CONTAINING R-1,3-BUTANEDIOL AND D-BETA-HYDROXYBUTYRIC ACID | STULII, VERA | — |
| 18894890 | BEVERAGE CONTAINING R-1,3-BUTANEDIOL OR R-1,3-BUTANEDIOL AND ETHANOL | STULII, VERA | — |
| Art Unit | Apps |
|---|---|
| 1652 | 4 |
| 1791 | 1 |
| 1792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19676472 | FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY | FRONDA, CHRISTIAN L | 1652 | §103DP | Non-Final OA | — | Pending | May 13, 2026 |
| 19578476 | R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT | FRONDA, CHRISTIAN L | 1652 | §103DP | Non-Final OA | — | Pending | Mar 25, 2026 |
| 19544207 | COMPOSITION OF D B-HYDROXYBUTYRATE SALTS | FRONDA, CHRISTIAN L | 1652 | DP | Final Rejection | — | Pending | Feb 19, 2026 |
| 19534368 | BEVERAGE CONTAINING R 1,3 BUTANEDIOL | STULII, VERA | 1791 | §102§103 | Final Rejection | — | Pending | Feb 09, 2026 |
| 19174611 | KETONE BEVERAGE CONTAINING CAFFEINE AND (R)-1,3-BUTANEDIOL AND/OR (R)-BETA-HYDROXYBUTYRIC ACID AND SALTS | ZILBERING, ASSAF | 1792 | §103§112 | Non-Final OA | — | Pending | Apr 09, 2025 |
| 18894874 | BEVERAGE CONTAINING R-1,3-BUTANEDIOL AND D-BETA-HYDROXYBUTYRIC ACID | STULII, VERA | — | §103Other | Non-Final OA | — | Pending | Sep 24, 2024 |
| 18894890 | BEVERAGE CONTAINING R-1,3-BUTANEDIOL OR R-1,3-BUTANEDIOL AND ETHANOL | STULII, VERA | — | §103Other | Non-Final OA | — | Pending | Sep 24, 2024 |
| 18678629 | EXOGENOUS KETONE BLEND COMPOSITIONS FOR DELIVERY OF KETONE BODIES | FRONDA, CHRISTIAN L | 1652 | DP | Final Rejection | 4d overdue | Pending | May 30, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial